These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28049407)

  • 1. Articular Bleeding in Hemophilia.
    Rodriguez-Merchan EC
    Cardiovasc Hematol Disord Drug Targets; 2016; 16(1):21-24. PubMed ID: 28049407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and patient outcomes of surgical intervention for hemophilic arthropathy.
    Rodriguez-Merchan EC
    Expert Rev Hematol; 2019 May; 12(5):325-333. PubMed ID: 30929534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of bleeding in hemophilia patients with high-titer inhibitors.
    Leissinger CA; Konkle BA; Antunes SV
    Expert Rev Hematol; 2015 Jun; 8(3):375-82. PubMed ID: 25937074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovitis in hemophilia: preventing, detecting, and treating joint bleeds.
    Rodriguez-Merchan EC
    Expert Rev Hematol; 2023; 16(7):525-534. PubMed ID: 37119182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of bypassing agents in patients with hemophilia and inhibitors: a systematic review and meta-analysis.
    Zhou ZY; Hay JW
    Clin Ther; 2012 Feb; 34(2):434-45. PubMed ID: 22285208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophilic arthropathy of the elbow: prophylaxis, imaging, and the role of invasive management.
    Dale TM; Saucedo JM; Rodríguez-Merchán EC
    J Shoulder Elbow Surg; 2015 Oct; 24(10):1669-78. PubMed ID: 26385390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and prevention of recurrent hemarthrosis in patients with hemophilia.
    Dunn AL
    Curr Opin Hematol; 2005 Sep; 12(5):390-4. PubMed ID: 16093785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor.
    Steen Carlsson K; Astermark J; Donfield S; Berntorp E
    Thromb Haemost; 2008 Jun; 99(6):1060-7. PubMed ID: 18521509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating recovery from acute hemarthrosis in patients with hemophilia: the role of joint aspiration.
    De la Corte-Rodriguez H; Rodriguez-Merchan EC; Alvarez-Roman MT; Martin-Salces M; Romero-Garrido JA; Jimenez-Yuste V
    Blood Coagul Fibrinolysis; 2019 Apr; 30(3):111-119. PubMed ID: 30958454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term effects of radioactive phosphorous synoviorthesis on hemophilic arthropathy.
    Eraghi AS; Kaseb MH; Espandar R; Mardookhpour S
    Blood Cells Mol Dis; 2015 Jun; 55(1):68-70. PubMed ID: 25976470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatological management of patients with hemophilia. Part 1: joint manifestations.
    Alcalay M; Deplas A
    Joint Bone Spine; 2002 Oct; 69(5):442-9. PubMed ID: 12477227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilic arthropathy: Current knowledge and future perspectives.
    Gualtierotti R; Solimeno LP; Peyvandi F
    J Thromb Haemost; 2021 Sep; 19(9):2112-2121. PubMed ID: 34197690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The target joint.
    Mulder K; Llinás A
    Haemophilia; 2004 Oct; 10 Suppl 4():152-6. PubMed ID: 15479389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico.
    Rodríguez-Zepeda MDC; González L; Bravo A; Pompa T; Silva S; Paredes R; García J; Ramos M; Wilkinson L; Lamotte M
    Value Health Reg Issues; 2018 Dec; 17():164-173. PubMed ID: 30317158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilic arthropathy: a teaching approach devoted to hemophilia treaters in under-development countries.
    Rodriguez-Merchan EC
    Expert Rev Hematol; 2021 Oct; 14(10):887-896. PubMed ID: 34482789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthopedic management of hemophilia.
    Heyworth BE; Su EP; Figgie MP; Acharya SS; Sculco TP
    Am J Orthop (Belle Mead NJ); 2005 Oct; 34(10):479-86. PubMed ID: 16304795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.
    Magisetty J; Pendurthi UR; Esmon CT; Rao LVM
    Blood; 2020 Jun; 135(25):2211-2223. PubMed ID: 32294155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hemophilia.
    Rodeghiero F
    Ric Clin Lab; 1985; 15(4):289-303. PubMed ID: 3914697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.